Neuroinflammation

Enteric glia (pink) and neurons (green), in colon myenteric plexus.

Courtesy of Elena Lucarini. © Epitech Group SpA

Investing in research, Innovating for health

Epitech Group was founded in 2001 to develop and disseminate a pioneering new approach to health research that, unlike conventional pharmacology, focuses on supporting the body’s self-regulation mechanisms, instead of inhibiting pathological stimuli.

Since then, we have studied and produced innovative formulations that convert progress in neuroscience into effective and safe solutions for clinical practice.

Looking at the complexity of the synaptic regulation variability, It is appealing to consider the idea of the discovery of new drugs for use in the nervous system, orientates the focus and efforts towards a biological modulation mechanisms, while learning from the nature how to design a pharmacology of modulation. [..]

Prof. Erminio Costa, Lectio Magistralis – Washington, 1986

Scientific commitment, based on clinical and preclinical evidence

Respect for nature, complex biological systems and people

Transparency and quality

Sustainability

Strategy and results

of turnover reinvested in research every year

0 %

international patents

0 +

years of scientific research

0 +

Mission and values

We strive to improve health and quality of life, by driving scientific research and tapping into the most recent discoveries concerning the nervous and immune systems, in order to transform them into resources able to promote the natural balance and functioning of our body.

This is the challenge for which we deploy our talents, the courage to pursue new ideas and our conviction in the revolutionary impact of research each and every day.

We are playing a responsible role in a project of individual and collective growth led by biological complexity, an asset of inestimable value to be protected and cared for.

We consider it equally important to cultivate the transparency and quality of processes and relationships at all levels, in order to focus on personal safety and the value of each project.

In research, we should try to imagine the strategy that Nature would use and when developing new medicines we need to go beyond where Nature leads us: these are the two great teachings that Nobel Prize for Medicine winner Rita Levi-Montalcini and the great pharmacologist of Italian origin Erminio Costa left me.

Francesco della Valle – Founder of Epitech Group